Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 507-514

  Li, Jian Hua ^a   Li, Peixiang ^a,b   Klamut, Henry ^a,b   Liu, Fei Fei ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P53;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRUSES, HUMAN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BETA-GALACTOSIDASE; CELL DIVISION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOMEGALOVIRUS; GENES, P53; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031005621     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Altun, M., Fandi, A., Dupuls, O., Cvitkovic, E., Krajina, Z., and Eschwege, F. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int. J. Radiat. Oncol. Biol. Phys., 32: 859-877, 1995.
2. Payne, D., Liu, F-F., O'Sullivan, B., Cummings, B. J., Keane, T., Warde, P., and McLean, M. Review of PMH experience with nasopharyngeal carcinoma. 4th International Conference on Head and Neck Cancer. Toronto, Canada, 1996.
3. Spitz, F., Nguyen, D., Skibber, J., Meyn, R., Cristiano, R., and Roth, J. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin. Cancer Res., 2: 1665-1671, 1996.
4. Mujoo, K., Maneval, D. C., Anderson, S. C., and Gutterman, J. U. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene, 12: 1617-1623, 1996.
5. Liu, T-J., El-Naggar, A., McDonnell, T., Steck, K., Wang, M., Taylor, D., and Clayman, G. L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
6. Katayose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K., and Seth, P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res., 1: 889-897, 1995.
7. Clayman, G., El-Naggar, A., Roth, J., Zhang, W-W., Goepfert, H., Taylor, D., and Liu, T. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
8. Cirielli, C., Riccioni, T., Yang, C., Pili, R., Gloe, T., Chang, J., Inyaku, K., Passaniti, A., and Capogrossi, M. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int. J. Cancer, 63: 673-679, 1995.
9. Yang, C., Cirielli, C., Capogrossi, M., and Passaniti, A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res., 55: 4210-4213, 1995.
10. Seth, P., Brinkmann, U., Schwartz, G., Katayose, D., Gress, R., Pastan, I., and Cowan, K. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res., 56: 1346-1351, 1996.
11. Nasrin, N., Taiba, K., Hannan, N. H. M., and Al-Sedairy, S. A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients. Cancer Lett., 82: 189-198, 1994.
12. Effert, P., McCoy, R., Abdel-Hamid, M., Flynn, K., Zhang, Q., Busson, P., Tursz, T., Liu, E., and Raab-Traub, N. Alterations of the p53 gene in nasopharyngeal carcinoma. J. Virol., 66: 3768-3775, 1992.
13. Lo, K-W., Mok, C-H., Huang, D. P., Liu, Y-X., Choi, P. H. K., Lee, J. C. K., and Tsao, S-W. p53 mutation in human nasopharyngeal carcinomas. Anticancer Res., 12: 1957-1964, 1992.
14. Sun, Y., Hegamyer, G. H., Cheng, Y. J., Hildesheim, A., Chen, J. Y., Chen, I-H., Cao, Y., Yao, K-T., and Colburn, N. H. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA, 89: 6516-6520, 1992.
15. Spruck, C. H., III, Tsai, Y. C., Huang, D. P., Yang, A. S., Rideout, W. M., III, Gonzalez-Zulueta, M., Choi, P., Lo, K-W., Yu, M. C., and Jones, P. A. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res., 52: 4787-4790, 1992.
16. Sheu, L-F., Chen, A., Tseng, H-H., Leu, F-J., Lin, J. K., Ho, K-C., and Meng, C-L. Assessment of p53 expression in nasopharyngeal carcinoma. Hum. Pathol., 26: 380-386, 1995.
17. Porter, M. J., Field, J. K., Lee, J. C. K., Leung, S. F., Lo, D., and Van Hasselt, C. A. Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res., 14: 1357-1360, 1994.
18. Zhang, Q., Gutsch, D., and Kenney, S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol., 14: 1929-1938, 1994.
19. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G., and Wiman, K. G. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA, 90: 5455-5459, 1993.
20. Pagano, J. S. The Epstein-Barr virus and nasopharyngeal carcinoma. Cancer (Phila.), 74: 2397-2398, 1994.
21. Zeng, Y. Establishment of an epithelioid cell line and a fusiform cell line from a patient with nasopharyngeal carcinoma. Sci. Sin., 21: 127, 1978.
22. Sizhong, Z., Xiukung, G., and Zeng, Y. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int. J. Cancer, 31: 587-590, 1983.
23. Marshall, R. S., Paterson, M. C., and Rauth, A. M. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer, 59: 341-346, 1989.
24. Kanegae, Y., Makimura, M., and Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol., 47: 157-166, 1994.
25. Graham, F. L., and Prevec, L. Manipulation of adenovirus vectors. In: E. J. Murray (ed.), Method in Molecular Biology, Vol. 7, pp. 109-128. Clifton, New Jersey: The Human Press Inc., 1991.
26. Zhang, W-W., Alemany, R., and Wang, J. A. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum. Gene Ther., 6: 155-164, 1995.
27. Zhang, W-W., Fang, X., Branch, C. D., Mazur, W., Prench, B. A., and Roth, J. A. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biol. Techniques, 15: 868-872, 1993.
28. Bonnerot, C., Rocancourt, D. M., Briand, P., Grimber, G., and Nicolas, J-F. A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc. Natl. Acad. Sci. USA, 84: 6795-6799, 1987.
29. Price, P., and McMillan, T. J. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res., 50: 1352-1396, 1990.
30. Vasconcelos, A. C., and Lam, K. M. Apoptosis induced by infectious bursal disease virus. J. Gen. Virol., 75: 1803-1806, 1994.
31. Fung, C. Y., and Fisher, D. E. p53: from molecular mechanisms to prognosis in cancer. J. Clin. Oncol., 13: 808-811, 1995.
32. Oltvai, Z., and Korsmeyer, S. Checkpoints of dueling dimers foil death wishes. Cell, 79: 189-192, 1994.
33. Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., and Raab-Traub, N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med., 333: 693-698, 1995.